Correction: Potent and specific MTH1 inhibitors targeting gastric cancer

Cell Death Dis. 2020 Oct 16;11(10):868. doi: 10.1038/s41419-020-03010-x.

¹ State Key Laboratory of Esophageal Cancer Prevention and Treatment; Key Laboratory of Advanced Pharmaceutical Technology Ministry of Education of China; School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China.
² Department of Pathology, Oslo University Hospital, Faculty of Medicine, University of Oslo, Oslo, 0379, Norway.
³ Department of Pathology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, 450001, China.
⁴ Department of General Surgery, Henan Provincial People's Hospital, Zhengzhou, Henan, 450001, China.
⁵ Department of Urology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, 0379, Norway.
⁶ State Key Laboratory of Esophageal Cancer Prevention and Treatment; Key Laboratory of Advanced Pharmaceutical Technology Ministry of Education of China; School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China. liuhm@zzu.edu.cn.
⁷ Department of Pathology, Oslo University Hospital, Faculty of Medicine, University of Oslo, Oslo, 0379, Norway. zhenhe.suo@medisin.uio.no.
⁸ State Key Laboratory of Esophageal Cancer Prevention and Treatment; Key Laboratory of Advanced Pharmaceutical Technology Ministry of Education of China; School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan, 450001, China. zhaowen@zzu.edu.cn.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.